Abstract

Recent introduction of 2 different lymphoma classifications has raised concerns about consistency in diagnosis, management, and clinical trial enrollment. Data from a large cohort reflecting real-world clinical practice suggest that differences between the classifications will affect <1% of non-Hodgkin lymphomas.

1.
Swerdlow
SH
,
Campo
E
,
Pileri
SA
, et al
.
The 2016 revision of the World Health Organization classification of lymphoid neoplasms
.
Blood
.
2016
;
127
(
20
):
2375
-
2390
.
2.
Alaggio
R
,
Amador
C
,
Anagnostopoulos
I
, et al
.
The 5th edition of the World Health Organization classification of haematolymphoid tumours: lymphoid neoplasms
.
Leukemia
.
2022
;
36
(
7
):
1720
-
1748
.
3.
Campo
E
,
Jaffe
ES
,
Cook
JR
, et al
.
The International Consensus Classification of mature lymphoid neoplasms: a report from the Clinical Advisory Committee
.
Blood
.
2022
;
140
(
11
):
1229
-
1253
.
4.
Cerhan
JR
,
Maurer
MJ
,
Link
BK
, et al
.
The lymphoma epidemiology of outcomes cohort study: design, baseline characteristics, and early outcomes
.
Am J Hematol
.
2024
;
99
(
3
):
408
-
421
.
5.
Matutes
E
.
Diagnostic and therapeutic challenges in hairy cell leukemia-variant: where are we in 2021?
.
Expert Rev Hematol
.
2021
;
14
(
4
):
355
-
363
.
6.
Teras
LR
,
DeSantis
CE
,
Cerhan
JR
,
Morton
LM
,
Jemal
A
,
Flowers
CR
.
2016 US lymphoid malignancy statistics by World Health Organization subtypes
.
CA Cancer J Clin
.
2016
;
66
(
6
):
443
-
459
.
7.
Xu
H
,
Yao
F
.
Primary testicular lymphoma: a SEER analysis of 1,169 cases
.
Oncol Lett
.
2019
;
17
(
3
):
3113
-
3124
.
8.
Soussain
C
,
Malaise
D
,
Cassoux
N
.
Primary vitreoretinal lymphoma: a diagnostic and management challenge
.
Blood
.
2021
;
138
(
17
):
1519
-
1534
.
9.
King
RL
,
Goodlad
JR
,
Calaminici
M
, et al
.
Lymphomas arising in immune-privileged sites: insights into biology, diagnosis, and pathogenesis
.
Virchows Arch
.
2020
;
476
(
5
):
647
-
665
.
10.
Chapuy
B
,
Roemer
MG
,
Stewart
C
, et al
.
Targetable genetic features of primary testicular and primary central nervous system lymphomas
.
Blood
.
2016
;
127
(
7
):
869
-
881
.
11.
Gibson
SE
,
Swerdlow
SH
.
How I diagnose primary cutaneous marginal zone lymphoma
.
Am J Clin Pathol
.
2020
;
154
(
4
):
428
-
449
.
12.
Maurus
K
,
Appenzeller
S
,
Roth
S
, et al
.
Panel sequencing shows recurrent genetic FAS alterations in primary cutaneous marginal zone lymphoma
.
J Invest Dermatol
.
2018
;
138
(
7
):
1573
-
1581
.
13.
Sarkozy
C
,
Hung
SS
,
Chavez
EA
, et al
.
Mutational landscape of gray zone lymphoma
.
Blood
.
2021
;
137
(
13
):
1765
-
1776
.
14.
Sarkozy
C
,
Chong
L
,
Takata
K
, et al
.
Gene expression profiling of gray zone lymphoma
.
Blood Adv
.
2020
;
4
(
11
):
2523
-
2535
.
15.
Ye
Q
,
Xu-Monette
ZY
,
Tzankov
A
, et al
.
Prognostic impact of concurrent MYC and BCL6 rearrangements and expression in de novo diffuse large B-cell lymphoma
.
Oncotarget
.
2016
;
7
(
3
):
2401
-
2416
.
16.
Cucco
F
,
Barrans
S
,
Sha
C
, et al
.
Distinct genetic changes reveal evolutionary history and heterogeneous molecular grade of DLBCL with MYC/BCL2 double-hit
.
Leukemia
.
2020
;
34
(
5
):
1329
-
1341
.
17.
Khurana
A
,
Mwangi
R
,
Cerhan
JR
, et al
.
Comparing clinical characteristics and outcomes of MYC and BCL6 double hit lymphoma (DHL-BCL6) with other aggressive B-cell lymphomas: understanding the impact of new WHO and International Consensus Classifications
.
Blood
.
2023
;
142
(
suppl 1
):
67
.
18.
Ennishi
D
,
Jiang
A
,
Boyle
M
, et al
.
Double-hit gene expression signature defines a distinct subgroup of germinal center B-cell-like diffuse large B-cell lymphoma
.
J Clin Oncol
.
2019
;
37
(
3
):
190
-
201
.
19.
King
RL
,
Hsi
ED
,
Chan
WC
, et al
.
Diagnostic approaches and future directions in Burkitt lymphoma and high-grade B-cell lymphoma
.
Virchows Arch
.
2023
;
482
(
1
):
193
-
205
.
20.
Coupland
SE
,
Du
MQ
,
Ferry
JA
, et al
.
The fifth edition of the WHO classification of mature B-cell neoplasms: open questions for research
.
J Pathol
.
2024
;
262
(
3
):
255
-
270
.
21.
Grever
M
,
Andritsos
L
,
Anghelina
M
, et al
.
Hairy cell leukemia variant and WHO classification correspondence Re: 5th edition WHO classification haematolymphoid tumors: lymphoid neoplasms
.
Leukemia
.
2024
;
38
(
7
):
1642
-
1644
.
22.
Falini
B
,
Martino
G
,
Lazzi
S
.
A comparison of the International Consensus and 5th World Health Organization classifications of mature B-cell lymphomas
.
Leukemia
.
2023
;
37
(
1
):
18
-
34
.
23.
Ng
SB
,
Chung
TH
,
Kato
S
, et al
.
Epstein-Barr virus-associated primary nodal T/NK-cell lymphoma shows a distinct molecular signature and copy number changes
.
Haematologica
.
2018
;
103
(
2
):
278
-
287
.
24.
Feldman
AL
,
Laurent
C
,
Narbaitz
M
, et al
.
Classification and diagnostic evaluation of nodal T- and NK-cell lymphomas
.
Virchows Arch
.
2023
;
482
(
1
):
265
-
279
.
25.
Hartmann
S
,
Eichenauer
DA
.
Nodular lymphocyte predominant Hodgkin lymphoma: pathology, clinical course and relation to T-cell/histiocyte rich large B-cell lymphoma
.
Pathology
.
2020
;
52
(
1
):
142
-
153
.
26.
Tousseyn
TA
,
King
RL
,
Fend
F
,
Feldman
AL
,
Brousset
P
,
Jaffe
ES
.
Evolution in the definition and diagnosis of the Hodgkin lymphomas and related entities
.
Virchows Arch
.
2023
;
482
(
1
):
207
-
226
.
You do not currently have access to this content.
Sign in via your Institution